Académique Documents
Professionnel Documents
Culture Documents
OH OH
O
O
OH
O O
H O
OH HO
n
VO LU M I Z I N G B I O D E G R A DA B L E
I N J E C TA B L E I M P L A N T
ON THE CUTTING EDGE OF SCIENCE
INTRODUCTION
DERMIS
1% Agarose (Low density)
N AT U R A L YO U T H F U L L O O K SUPERFICIAL 2,5%
Sub-dermal
1,5%
Agarose (Low density)
H
OH OH
O
O
OH
O
O
HO
O
OH
W I T H I M M E D I AT E R E S U LT S
(High density) 3,5%
Deep
DEEP sub-dermal Agarose (High density)
HYPODERMIS hypo-dermis and
supra peri-osteal
MUSCLE
BONE
ALGENESS® A BREAKTHROUGH
IN THE SUBDERMAL FILLER INDUSTRY Algeness agarose gel structure Algeness fillers depth of injection Immediate and safe mastered result.
Agarose is an hydrocolloid molecule
containing water in its structure
Algeness® is a biomaterial consisting of For the first time in the aesthetic medi-
a purified agarose gel (polysaccharide), cine history, a 100% natural, biocompa-
derived from a sophisticated manufactu- tible and biodegradable injectable im-
ring process. plant is available on the market fulfilling
The molecular and biophysical properties the expectations and requirements of BUILDING YOUR CONFIDENCE
of AAT’s agarose make it a breakthrough the most demanding practitioners. KNOWING ALGENESS® IS:
in the filler’s injection technology.
The fulfilment of the patients’ require- injection technique which we call “Master
ments is a challenge when the results Your Results®” The right filler is very im-
must be achieved immediately and safely portant, when the physician is requested
Bibliographic References:
with a all natural look and this can be to deliver immediate results safely, confi- [1] Joergensen, P., M.D. and Adamsen, R. “Efficacy, safety and rate of absorption of Agarose for facial
done with the confidence of a controlled dently and with precision. soft-tissue augmentation. Data on file
[2] Comparative implantation in mice: Wake Forest University. 2013 and 2014
[3] Motolese, P. MD Agarose gel long-lasting absorbable filler
Data on file. (Member of SIES and Prof. AMS – Bologna)
[6]
[1 ]
[7]
Product LD
1%
HD
1,5%
VL
2,5%
DF
3,5%
[5]
Charm
[3] [2]
Indication Tear trough Marionette lines, Medium-deep volumizing Deep volumetric filling
Lips augmentation wrinkles, and furrows Wrinkles, furrows and Cheeks , jawline and chin
and contouring Lip augmentation folds Nasolabial folds
and contouring Cheeks, jawline and chin Malar-zygomatic arch
Oral commissure Nasolabial folds Submalar
Oro-mandibular folds Malar and Submalar Non surgical
Non-surgical rhinoplasty nose rhinoplasty
Follow up After 7-10 days if After 7-10 days if After 7-10 days if After 7-10 days if
additional corrections additional corrections are additional corrections additional corrections A R E A S O F A P P L I C A T I O N
are required required are required are required
Each box 2 disposable “full-use” 2 disposable “full-use” 2 disposable “full-use” 2 disposable “full-use”
Depth of injection: [ 2 ] Lip augmentation Cheeks, jawline and chin [ 7 ] Malar-zygomatic arch
contains 0.5 ml double Luer Lock 1.4 ml double Luer 1.4 ml double Luer Lock 1.4 ml double Luer Lock subdermal and contouring Nasolabial folds temple Submalar
syringe systems, Lock syringe systems, 2 syringe systems, syringe systems, [ 4 ] Oral commissure Non-surgical rhinoplasty Depth of injection:
2 needles per syringe. needles per syringe. 2 needles per syringe. 2 needles per syringe. Oro-mandibular folds Depth of injection: Subcutaneous
Depth of injection: supra-periosteal Supraperiosteal
Shelf life 2 years 2 years 2 years 2 years subdermal Subcutaneous
A d v a n c e d A e s t h e t i c Te c h n o l o g i e s , I n c